Evidence map›Paper›PMID 30050587›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

The Effectiveness of Saireito, a Traditional Japanese Herbal Medicine, in Reducing Postoperative Edema after Acquired Ptosis Surgery: A Prospective Controlled Trial.

Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Atsuyuki Kuro, Yuko Ueda, Masakatsu Hihara, Yoshihito Tanaka, Yujiro Ozaki, Kenji Suzuki, Kenji Kusumoto

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Naoki MorimotoDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, Japan.ORCID 0000-0002-0712-3172
Natsuko KakudoDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, Japan.
Toshihito MitsuiDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, Japan.
Atsuyuki KuroDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, Japan.
Yuko UedaDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, Japan.
Masakatsu HiharaDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, Japan.
Yoshihito TanakaDepartment of Plastic and Reconstructive Surgery, Kansai Medical University Medical Center, Japan.
Yujiro OzakiDepartment of Plastic and Reconstructive Surgery, Kansai Medical University Medical Center, Japan.
Kenji SuzukiDepartment of Plastic and Reconstructive Surgery, Kansai Medical University Medical Center, Japan.
Kenji KusumotoDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, Japan.
Kansai Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPersistent edema is a common complication after the surgical treatment of blepharoptosis; however, no objective methods have been established for evaluating or treating this condition. We focused on the Japanese herbal medicine, Saireito, and evaluated its efficacy in reducing postoperative edema.

methodsThis was a prospective, nonrandomized, and controlled study. We evaluated the incidence of postoperative edema in a Control group using a subjective patient-assessed visual analog scales (VASs) to assess swelling, pain, itching, and local warmth and an objective surgeon-assessed VAS to evaluate swelling. Swelling was also assessed by an objective computer-based analysis of digital images. These methods were used to evaluate the effects of Saireito (8.1 g/day) for 8 weeks.

resultsA total of 49 patients and 80 eyelids were enrolled. Twenty-nine patients and 48 eyelids were assigned to the Control group, and 20 patients and 32 eyelids were assigned to the Saireito group. Our analysis of the Control group indicated that postoperative edema persisted for up to 8 weeks. On the other hand, the postoperative edema in the Saireito group was mostly eliminated at 8 weeks. The computer-based analysis of digital images showed that the edema tended to be reduced in the Saireito group compared with the Control group.

conclusionSaireito might be effective for reducing postoperative edema after blepharoptosis surgery and almost completely eliminated it at 8 weeks after surgery. This study was a preliminary and nonrandomized study; therefore, the randomized and placebo-controlled study will be needed in the next step.

Identifiers

PMID30050587
PMCPMC6040292
OpenAlexW2809889406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.